Therapeutic effect of everolimus on small renal angiomyolipoma in cases of tuberous sclerosis complex-related epilepsy and subependymal giant cell astrocytoma

Takashi Hatano; Yasuhiro Yuri

doi:10.1016/j.asjsur.2022.08.041

Therapeutic effect of everolimus on small renal angiomyolipoma in cases of tuberous sclerosis complex-related epilepsy and subependymal giant cell astrocytoma

Asian J Surg. 2023 Mar;46(3):1236-1237. doi: 10.1016/j.asjsur.2022.08.041. Epub 2022 Aug 26.

Authors

Takashi Hatano¹, Yasuhiro Yuri²

Affiliations

¹ Department of Urology, Seirei Yokohama Hospital, Kanagawa, Japan. Electronic address: t-hatano@sis.seirei.or.jp.
² Department of Urology, Seirei Yokohama Hospital, Kanagawa, Japan.

PMID: 36031512
DOI: 10.1016/j.asjsur.2022.08.041

No abstract available

Keywords: Epilepsy; Everolimus; Mammalian target of rapamycin inhibitor; Renal angiomyolipoma; Subependymal giant cell astrocytoma; Tuberous sclerosis complex.

Publication types

Letter

MeSH terms

Angiomyolipoma* / complications
Angiomyolipoma* / drug therapy
Antineoplastic Agents* / therapeutic use
Astrocytoma* / complications
Astrocytoma* / diagnostic imaging
Astrocytoma* / drug therapy
Epilepsy* / drug therapy
Everolimus / therapeutic use
Hamartoma*
Humans
Kidney Neoplasms* / complications
Kidney Neoplasms* / drug therapy
Tuberous Sclerosis* / complications

Substances

Everolimus
Antineoplastic Agents